Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Specific criteria for assessment of endoscopic efficacy parameters and scoring system

From: The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study

Parameter Description Score Final overall score of endoscopic changes
Mucous accumulation Absent 0 0–2 (−) absent
3–5 (+) mild
6–9 (++) moderate
9 (+++) severe
Serous/ sero-mucous, small amount- mild 1
Mucous/ sero- purulent, small amount- moderate 2
Purulent/ muco-purulent/ haemorrhagic, large amount- severe 3
Severity of hyperaemia Absent/ normal mucosa 0
Mild (present in less than 20% of nasal cavity) 1
Moderate (20–40% of nasal cavity) 2
Severe (> 40% of nasal cavity) 3
Turbinate oedema Absent/normal mucosa 0
Oedematous mucosa 1
Marked oedema 2
Polypoid mucosa 3